GE HealthCare (GEHC) has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for View, a zero-footprint diagnostic viewer that serves as the key component of its Genesis Radiology Workspace.
View supports 2D and 3D visualization and AI-enabled tools for clinical decision-making, according to the company. It also provides access to advanced visualization applications within a single workflow and is designed to allow radiologists to work remotely with full diagnostic capability, GE HealthCare said.
View is currently available in the U.S.
